Combined pituitary hormone deficiency caused by a missense de novo variant in FGFR1
Abstract
Heterozygous loss-of-function variants of fibroblast growth factor receptor 1 (FGFR1) are associated with Kallmann syndrome (KS) with anosmia/hyposmia, Congenital Hypogonadotropic Hypogonadism (CHH) with normosmia and Septo-Optic Dysplasia (SOD) and only occasionally with Combined Pituitary Hormone Deficiency (CPHD).We report the case of a 14-year-old boy who came to our attention for short stature and pubertal delay. The patient had a medical history of cleft lip and cryptorchidism, surgically corrected during childhood.Endocrinological investigation, including endocrine dynamic function test, documented a growth hormone deficiency and hypogonadotropic hypogonadism (HH), while the other pituitary tropin hormones were within normal range. Brain magnetic resonance imaging revealed a complex malformation of the midline and maxillofacial bones, with hypoplastic olfactory sulci, caudal dislocation of the fronto-basal cortical gyri, impaired cranio-caudal development of the nasal pits, nasal septal deviation, defect of the alveolar process of the maxillary bone, maxillary and frontal sinuses hypoplasia and one palatalized supernumerary tooth. Nevertheless, pituitary gland was normal and the pituitary stalk was in axis. Despite, these radiological findings no anosmia was reported. Trio exome sequencing analysis identified a de novo heterozygous missense variant c.2002G>A in FGFR1 gene, that determines the aminoacidic change p. Glu668Lys, confirming the diagnosis of CPHD.Recombinant growth hormone and testosterone therapies were started, resulting in significant height recovery and in the development of secondary sexual characteristics.In conclusion, the comprehensive study of pituitary function, brain MRI and genetic analysis are crucial in the diagnostic work-up of HH in order to clarify its etiology and any associated comorbidities.
Keywords
Full Text:
PDFReferences
1. Bosch I Ara, L., Katugampola, H., Dattani, MT. (2021) Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome. Front Pediatr; 8:600962. doi: 10.3389/fped.2020.600962.
2. Raivio T., Avbelj M., McCabe MJ., Romero CJ., Dwyer AA., Tommiska J., Sykiotis, GP., Gregory, LC., Diaczok, D., Tziaferi, V., Elting, MW., Padidela, R., Plummer, L., Martin, C., Feng, B., Zhang, C., Zhou, QY., Chen, H., Mohammadi, M., Quinton, R., Sidis, Y., Radovick, S., Dattani, MT., Pitteloud, N. (2012) Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 2012; 97:694–9. doi: 10.1210/jc.2011-2938.
3. Norlin, S., Nordström, U., Edlund, T. (2000) Fibroblast growth factor signaling is required for the proliferation and patterning of progenitor cells in the developing anterior pituitary. Mech Dev.; 96(2):175-82. doi: 10.1016/s0925-4773(00)00393-2.
4. Arauz, RF., Solomon, BD., Pineda-Alvarez, DE., Gropman, AL., Parsons, JA., Roessler, E., Muenke, M. (2010) A Hypomorphic Allele in the FGF8 Gene Contributes to Holoprosencephaly and Is Allelic to Gonadotropin-Releasing Hormone Deficiency in Humans. Mol Syndromol; 1(2):59-66. doi: 10.1159/000302285.
5. Koika, V., Varnavas, P., Valavani, H., Sidis, Y., Plummer, L., Dwyer, A., Quinton, R., Kanaka-Gantenbein, C., Pitteloud, N., Sertedaki, A., Dacou-Voutetakis, C., Georgopoulos, N. A. (2013) Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH), Gene; 1;516(1):146-51. doi: 10.1016/j.gene.2012.12.041.
6. Boehm, U., Bouloux, PM., Dattani, MT., de Roux, N., Dodé, C., Dunkel, L., Giacobini, P., Hardelin, JP., Juul, A., Maghnie, M., Pitteloud, N., Prevot, V., Raivio, T., Tena-Sempere, M., Quinton, R., Young, J. (2015) Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol; 11: 547–64. doi: 10.1038/nrendo.2015.112.
7. Sano, S., Masunaga, Y., Kato, F., Fujisawa, Y., Saitsu, H., Ogata, T. Combined pituitary hormone deficiency in a patient with an FGFR1 missense variant: case report and literature review. (2022) Clin Pediatr Endocrinol.; 31(3):172-177. doi: 10.1297/cpe.2022-0020.
8. Di Iorgi, N., Morana, G., Allegri, AE., Napoli, F., Gastaldi, R., Calcagno, A., Patti, G., Loche, S., Maghnie, M. (2016) Classical and non-classical causes of GH deficiency in the paediatric age. Best Pract Res Clin Endocrinol Metab.; 30(6):705-736. doi: 10.1016/j.beem.2016.11.008.
9. Erbaş, İM., Paketçi, A., Acar, S., Kotan, LD., Demir, K., Abacı, A., Böber, E. (2020) A nonsense variant in FGFR1: a rare cause of combined pituitary hormone deficiency. J Pediatr Endocrinol Metab; 33: 1613–5. doi: 10.1515/jpem-2020-0029.
10. Correa, FA., Trarbach, EB., Tusset, C., Latronico, AC., Montenegro, LR., Carvalho, LR., Franca, MM., Otto, AP., Costalonga, EF., Brito, VN., Abreu, AP., Nishi, MY, Jorge, AA., Arnhold, IJ., Sidis, Y., Pitteloud, N., Mendonca, BB. (2015) FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies. Endocr Connect; 4: 100–7. doi: 10.1530/EC-15-0015.
Fukami, M., Iso, M., Sato, N., Igarashi, M., Seo, M., Kazukawa, I., Kinoshita, E., Dateki, S., Ogata, T. (2013) Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency. Endocr J; 60: 1013–20. doi: 10.1507/endocrj.ej13-0023
DOI: https://doi.org/10.13129/1828-6550/APMB.112.2.2024.CCS3
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Tiziana Abbate, Paola Cavallaro, Aurora Lanzafame, Maria Francesca Messina, Agata Vitale, Malgorzata Wasniewska, Domenico Corica
This work is licensed under a Creative Commons Attribution 4.0 International License.